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A recently reported paper by Rivers et al. [1] describes a
pivotal study that clearly demonstrates that early goal-
directed therapy has a significant role to play in the
management of the critically ill septic patient. This of course
contradicts the results obtained both by Hayes et al. [2] and
Gattinoni et al. [3]. Those groups demonstrated that
targeting oxygen delivery to a level of 600 ml/min per m2 or a
mixed venous saturation greater than 70% did not improve
outcome, and indeed increased mortality in a subgroup of
patients [4] who were unable to reach the target values.
The most surprising finding in the study reported by Rivers et
al. [1] was the baseline value of 48% for central venous
saturations. This demonstrates that patients with severe
sepsis/septic shock when first admitted to the emergency
room of a large US hospital must have extremely low cardiac
outputs, implying severe hypovolaemia, although there is also
likely to be significant myocardial depression. Those of us
working in the intensive care unit (ICU) environment rarely
encounter values as low as this in septic patients, presumably
because most patients will have already received at least
some volume resuscitation before admission to the ICU.
Rivers et al. chose central venous saturation and lactate as
targets for their ‘early goal-directed therapy’ protocol, with
the aim of achieving central venous saturation of greater than
70% and lactate of less than 2 mmol/l while the patients
remained in the emergency room. These were presumably
chosen as relatively simply measured variables that act as
surrogates for cardiac output. The strict protocol they
employed involved aggressive volume resuscitation, including
early blood transfusion and inotrope administration, during
the 7-h period that the patients remained in the emergency
room before transfer to the ICU.
In the protocol group the targets were achieved within 3 h;
those patients received 1.5 l extra fluid during the period
spent in the emergency room, with 64% receiving blood
transfusions as compared with only 18.5% in the control
group. In addition, 13.7% of patients in the protocol group
received inotropes versus fewer than 1% in the control
group. Just over 50% of patients in both groups were
ventilated during this period.
Sixty-five hours after admission to the ICU (the staff of which
had no knowledge as to which group the patients had been
assigned) the situation was reversed, with the control group
now receiving significantly more fluid, blood transfusions and
vasopressors. In addition, only a further 2.6% of patients in
the protocol group required ventilation as compared with
16.8% in the control group. Similarly, almost twice as many
patients in the control group were deemed to require
insertion of a pulmonary artery catheter during their stay in
the ICU.
Clearly the results are of great significance. First, the study
suggests that hypovolaemia is an important and
unrecognized problem in septic patients admitted to the
emergency room. Second, the treatment received by the
patients in the control group was clearly suboptimal, although
such treatment would certainly be accepted in most
institutions as a good standard of care. These patients after
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all certainly received resuscitation, as reflected by the
increase in central venous saturation and fall in lactate seen
at 3 h. Third, aggressive protocols can be undertaken in the
emergency room using variables that are relatively
noninvasive and simple to measure. Finally, aggressive early
resuscitation led to a dramatic difference in the subsequent
clinical course. Thus, patients in the protocol group were
judged as less sick by the ICU staff, requiring less fluid, with
a lower incidence of ventilation and pulmonary artery
catheterization, and with lower levels of inflammatory markers.
These findings in themselves would be only of academic
interest if it were not for the dramatic effects on mortality. An
absolute reduction of 16% in hospital mortality is an
astonishing result, particularly as the effect persisted to 60
days when the absolute difference in mortality was 12.6%,
which was still statistically significant. These benefits are
clearly superior to all of those reported by intervention studies
during the past 20 years, and the mortality benefit is almost
three times better than the results obtained in the recently
reported Recombinant Human Activated Protein C Worldwide
Evaluation in Severe Sepsis (PROWESS) study [5].
The study reported by Rivers et al. [1] probably requires
repeating to confirm the findings, but does of course have
profound implications for clinical practice in emergency
rooms and ICUs, and probably also in general medical and
surgical wards. It strongly suggests that septic patients are
still not being adequately resuscitated early enough in the
course of the illness, and that targeting this resuscitation to
clearly defined and easily measurable end-points is the most
appropriate course of action. It is not often that one has the
opportunity of commenting on such an important contribution
to the medical literature, but this study does appear to be
one of those rarities.
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